The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 174: ASCO 2022: Cell free DNA as a biomarker in bladder cancer
24 minutes
Posted Jun 3, 2022 at 11:38 pm.
0:00
24:39
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Amir Goldkorn describes translational findings from a phase 2 bladder trial.
Previous
Episode 173: ASCO 2022: The Atlantis Trial - maintenance cabozantinib in bladder cancer
Next
Episode 175: ASCO 2022: Targeting the microbiome in renal cancer
← See all 495 episodes of The Uromigos